Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception

European Journal of Pharmacology

Volumn 308, Issue 2, 1996, Pages 125-133

  Galeotti, Nicoletta ^a   Ghelardini, Carla ^a   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

analgesia; baclofen; clomipramine; diphenhydramine; morphine; pertussis toxin; physost igmine

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; BACLOFEN; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLOMIPRAMINE; DIPHENHYDRAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; OPIATE; PERTUSSIS TOXIN; PHYSOSTIGMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030592142     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00299-3     Document Type: Article

References (56)

1. 2-agonists in locus coeruleus neurons, Brain Res, 371, 390.
2. Arrang, J.M., 1994, Pharmacological properties of histamine receptor subtypes, Cell. Mol. Biol. 40, 275.
3. Bartolini, A., C. Ghelardini, L. Fantetti, M. Malcangio, P. Malmberg-Aiello and A. Giotti, 1992, Role of muscarinic receptor subtypes in central antinociception, Br. J. Pharmacol. 105, 77.
4. Birnbaumer, L., 1990, G proteins in signal transduction, Annu. Rev. Pharmacol. Toxicol. 30, 675.
5. Bodnar, R.J., D. Paul, M. Rosenblum, L. Liu and G.W. Pasternak, 1990, Blockade of morphine analgesia by both pertussis toxin and cholera toxin in the periaqueductal gray and locus coeruleus, Brain Res. 529, 324.
6. Bourne, H.R., D.A. Sanders and F. McCormick, 1990, The GTPase superfamily: a conserved switch for diverse cell function, Nature 348, 125.
7. Bourne, H.R., D.A. Sanders and F. McCormick, 1991, The GTPase superfamily: conserved structure and molecular mechanism, Nature 349, 117.
8. Brown, A.M. and L. Birnbaumer, 1990, Ionic channels and their regulation by G protein subunits, Annu. Rev. Physiol. 52, 197.
9. Campos, V.M. and E.L. Solis, 1980, The analgesic and hypothermic effects of nefopam, morphine, aspirin, diphenhydramine and placebo, J. Clin. Pharmacol. 20, 42.
10. Caulfield, M.P., 1993, Muscarinic receptors-Characterization, coupling and function, Pharmacol. Ther. 58, 319.
11. Chang, S.C., K. Lufty, V. Sierra and B.C. Yoburn, 1991, Dissociation of opioid receptor upregulation and functional supersensitivity, Pharmacol. Biochem. Behav. 38, 853.
12. Childers, S.R., 1991, Opioid receptor-coupled second messenger systems, Life Sci. 48, 1991.
13. Chung, K.M., D.K. Song, H.W. Suh, M.H. Lee and Y.H. Kim, 1994, Effect of intrathecal or intracerebroventricular pretreatment with pertussis toxin on antinociception induced by β-endorphin or morphine administered intracerebroventricularly in mice, Naunyn-Schmied. Arch. Pharmacol. 349, 588.
14. Damaj, M.I., S.P. Welch and B.R. Martin, 1994, Nicotine-induced antinociception in mice: role of G-proteins and adenylate cyclase, Pharmacol. Biochem. Behav. 48, 37.
15. Dolphin, A.C. and R.H. Scott, 1987, Calcium channel currents and their inhibition by (-)-baclofen in rat sensory neurones: modulation by guanine nucleotides, J. Physiol. 386, 1.
16. Dunwiddie, T.V. and M.T. Su, 1988, Pertussis toxin pretreatment antagonizes the actions of mu-and delta-opiate agonists in hippocampal slices, Neurosci. Lett. 95, 329.
17. + channels by GABA, Trends Neurosci. 15, 46.
18. + current in voltage-clamped CA3 pyramidal cells in hippocampal cultures, Proc. Natl. Acad. Sci. USA 82, 1558.
19. Galeotti, N., C. Ghelardini and A. Bartolini, 1995. Involvement of the serotoninergic system in the analgesic effect of tricyclic antidepressants, Behav. Pharmacol. 6 (Suppl. 1), 20.
20. Graziano, M.P. and A.G. Gilman, 1987, Guanine nucleotide-binding regulatory proteins: mediators of transmembrane signaling, Trends Pharmacol. Sci. 8, 478.
21. Haley, T.J. and G.L. McCormick, 1957, Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse, Br. J. Pharmacol. Chemother. 12, 12.
22. Harris, L.S., W.L. Dewey, J. Howes, J.S. Kennedy and H. Pars, 1969, Narcotic antagonists analgesics: interaction with cholinergic system, J. Pharmacol. Exp. Ther. 169, 17.
23. Hepler, J.R. and A.G. Gilman, 1992, G proteins, Trends Biochem. Sci. 17, 383.
24. B receptor modulation of adenylate cyclase activity in rat brain slices, Br. J. Pharmacol. 84, 249.
25. Hill, S.J., 1990, Distribution, properties, and functional characteristics of three classes of histamine receptor, Pharmacol. Rev. 42, 45.
26. Hille, B., 1994, Modulation of ion-channel function by G-protein-coupled receptors, Trends Neurosci. 17, 531.
27. Hoehn, K., A. Reid and J. Sawynok, 1988, Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen, Eur. J. Pharmacol. 146, 65.
28. Holz, G.G., S.G. Rane and K. Dunlap, 1986, GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels, Nature 319, 670.
29. Hood, D.D., J.C. Eisenach and R. Tuttle, 1995, Phase I safety assessment of intrathecal neostigmine methylsulphate in humans, Anesthesiology 82, 331.
30. B agonists and antagonists on transmitter release and somatic calcium channel currents in cultured neurons, Neuroscience 38, 721.
31. Katada, T. and M. Ui, 1982, Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP ribosilation of a membrane protein, Proc. Natl. Acad. Sci. USA 79, 3129.
32. Katada, T., G.M. Bokoch, J.K. Northup, M. Ui and A.G. Gilman, 1984, The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and functions of the purified protein, J. Biol. Chem. 259, 3568.
33. Langohr, H.D., M. Stöhr and F. Petruch, 1982, An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono-and polyneuropathies, Eur. Neurol. 2, 309.
34. Loh, H.H. and A.P. Smith, 1990, Molecular characterization of opioid receptors, Annu. Rev. Pharmacol. Toxicol. 30, 123.
35. Lucas, J.J. and R. Hen, 1995, New players in the 5-HT receptor field: genes and knochout, Trends Pharmacol. Sci. 16, 246.
36. McDonald, R.L., J.H. Skerritt and M.A. Werz, 1986, Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture, J. Physiol. 370, 75.
37. 11α equally and non-selectively, FEBS 324 (2), 241.
38. 3H-nitrendipine binding to synaptic membranes: similarity with morphine tolerance, Naunyn-Schmied. Arch. Pharmacol. 341, 123.
39. Oluyomi, A.O. and S.L. Hart, 1991, Involvement of histamine in naloxone-resistant and naloxone-sensitive models of swim stress-induced antinociception in the mouse, Neuropharmacology 30 (9), 1021.
40. Parenti, M., F. Tirone, G. Giagnoni, N. Pecora and D. Parolaro, 1986, Pertussis toxin inhibits the antinociceptive action of morphine in the rat, Eur. J. Pharmacol. 124, 357.
41. Park, D., D.Y. Jhon, C.W. Lee, K.H. Lee and S.G. Rhee, 1993, Activation of phospholipase C isozymes by G protein beta gamma subunits, J. Biol. Chem. 268, 4573.
42. Parolaro, D., G. Patrini, G. Giagnoni, P. Massi, A. Groppetti and M. Parenti, 1990, Pertussis toxin inhibits morphine analgesia and prevents opiate dependence, Pharmacol. Biochem. Behav. 35, 137.
43. Raffa, R.B., R.P. Martinez and C.D. Connelly, 1994, G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception, Eur. J. Pharmacol. 258, R5.
44. Rumore, M.M. and D.A. Schlichting, 1985, Analgesic effects of antihistaminics, Life Sci. 36, 403.
45. Sabol, S.L. and M. Nirenberg, 1979, Regulation of adenylate cyclase of neuroblastoma × glioma hybrid cells by α-adrenergic receptors, J. Biol. Chem. 254, 1913.
46. Sacerdote, P., A. Brini, P. Mantegazza and A.E. Panerai, 1978, A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs, Pharmacol. Biochem. Behav. 26,153.
47. 2-mediated supraspinal analgesia in mice, Life Sci. 48, 1721.
48. Sawynok, J. and A. Reid, 1988, Role of G-proteins and adenylate cyclase in antinociception produced by intrathecal purines, Eur. J. Pharmacol. 156, 25.
49. Sharma, S.K., M. Nirenberg and W.A. Klee, 1975, Morphine receptors as regulators of adenylate cyclase activity, Proc. Natl. Acad. Sci. USA 72, 590.
50. Simon, M.I., M.P. Strathman and N. Gautman, 1991, Diversity of G proteins in signal transduction, Science 252, 802.
51. Suzuki, T., M. Funada, M. Narita, M. Misawa and H. Nagase, 1991, Pertussis toxin abolishes mu-and delta-opioid agonist-induced place preference, Eur. J. Pharmacol. 205, 85.
52. Trussel, L.O. and M.B. Jackson, 1987, Dependence of an adenosine-activated potassium current on a GTP-binding protein in mammalian central neurons, J. Neurosci. 7, 3306.
53. Van Calker, D., M. Müller and B. Hamprecht, 1979, Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells, J. Neurochem. 33, 999.
54. Van der Ploeg, I., A. Cintra, N. Altiok, P. Askelöf, K. Fuxe and B.B. Fredholm, 1991, Limited distribution of pertussis toxin in rat brain after injection into the lateral cerebral ventricles, Neuroscience 44 (1), 205.
55. Vaught, J.L., K. Pelley, L.G. Costa, P. Seder and S.J. Enna, 1985, A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen, Neuropharmacology 24, 211.
56. Wojcik, W.J. and N.H. Neff, 1984, γ-Aminobutyric acid B receptors are negatively coupled to adenylate cyclase in brain, and in the cerebellum these receptors may be associated with granule cells, Mol. Pharmacol. 25, 24.